+ All Categories
Home > Documents > The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating...

The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating...

Date post: 03-Jun-2020
Category:
Upload: others
View: 2 times
Download: 0 times
Share this document with a friend
68
The Underlying Pathology of Chronic Disease DEBBY HAMILTON, M.D., MPH AARM SEPTEMBER 2018 FINANCIAL DISCLOSURE: MEDICAL DIRECTOR OF RESEARCHED NUTRITIONALS 1
Transcript
Page 1: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

The Underlying Pathology of Chronic Disease

DEBBY HAMILTON, M.D., MPH

AARM SEPTEMBER 2018

FINANCIAL DISCLOSURE: MEDICAL

DIRECTOR OF RESEARCHED NUTRITIONALS

1

Page 2: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

2

Page 3: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Lyme Disease 3

Page 4: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

4

Page 5: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

5

Page 6: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

How we

learned

to

practice

medicine

6

Page 7: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Symptoms

Diagnosis

Prescription

7

Page 8: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Treatment by cause of

symptoms

Symptoms

Biologic

Cause

Treatment

Plan

8

Page 9: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Common Symptoms in

Chronic Disease

9

Page 10: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Fatigue

10

Page 11: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Poor recovery from exercise

Poor endurance11

Page 12: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Fatigue in children

12

Page 13: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

13

Page 14: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

14

Page 15: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Mitochondrial

Function

1. ATP production-produce

energy for the cell

2. Initiating and performing

apoptosis and cell death

3. Calcium homeostasis

4. Iron homeostasis

15

Page 16: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

“”

Children with autism were more likely

to have mitochondrial dysfunction,

mtDNA over replication, and mtDNA

deletions than typically developing

children.

MITOCHONDRIAL DYSFUNCTION IN AUTISM

Giolivi C. et al. Mitochondrial dysfunction in autism

JAMA. 2010 December 1; 304(21): 2389–2396.

16

Page 17: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

17

Page 18: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Oxidative Stress 18

Definition

Imbalance between the

production of free

radicals and the ability

of the body to

counteract or detoxify

their harmful effects

through neutralization by

antioxidants

Page 19: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Causes of

Mitochondrial Dysfunction

and Oxidative Stress

Mitochondrial

Dysfunction

Medicines

Poor Nutrition

Stress

Pesticides

(Glyphosate)

Heavy Metals

Environmental toxins

Oxidative Stress

Medicines

Poor Nutrition

Stress

Pesticides

(Glyphosate)

Heavy Metals

Environmental Toxins

19

Page 20: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Oxidative Stress in Autism

Research comparing anti-oxidant markers and

markers of lipid peroxidation to assess oxidative

stress

Study population: 20 children with ASD

25 matched healthy controls

Results: Positive in ASD children younger than 6

yrs

Decreased anti-oxidant markers with SOD and

GSH-PX

Increase in lipid peroxidation marker MDA

Meguid, N.A., Dardir, A.A., Abdel-Raouf, E.R. et al. Biol Trace Elem Res (2011) 143: 58.

doi:10.1007/s12011-010-8840-9

20

Page 21: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Increasedoxidative

stress

Then:

21

Increased

need for

glutathione

Page 22: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

What are the functions of Glutathione?

1. Master Antioxidant

2. Reduces Free Radicals

3. Detoxifies Chemicals

4. Chelates Heavy Metals

5. Protects Mitochondrial DNA

6. Cellular Anti-inflammatory compound

7. Storage and transport of cysteine

8. Enhances immune function

and transport of cysteine

22

Page 23: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Environmental Chemicals:

Depletion of glutathione

Tylenol

Acetone/solvents

Fuel/gasoline

Heavy Metals

Pesticides/Herbicides

Nitrates: Food

preservatives

Artificial sweeteners

Synthetic food dyes

Benzopyrenes: tobacco

Industrial pollutants

Ethanol

Household chemicals:

detergents, cleaners,

bleach

Plastics

Non-stick cookware

Chlorine treated water

Formaldehydes

X-rays

EMF’s

UV radiation

23

Page 24: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Brain Glutathione Levels – A Novel Biomarker for Mild

Cognitive Impairment and Alzheimer’s Disease. Mandal,

Pravat K. et al. Biological Psychiatry , Volume 78 , Issue 10 , 702

- 710

Alzheimer’s disease dependent reduction of GSH

was observed in both Hippocampus and Frontal

C (p < 0.001).

GSH reduction in these regions correlated with

decline in cognitive functions.

Hippocampal GSH discriminates between mild

cognitive impairment and healthy controls

24

Page 25: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Chronic Pain 25

Page 26: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

26

Page 27: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

27

Page 28: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

28

Page 29: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Acute Inflammation

Normal immune response to injury or infection

Chronic Inflammation

Prolonged abnormal immune response

Oxidative Stress

Normal part of metabolism and immune

response

Chronic Oxidative Stress

Destructive process that damages DNA and

cell membranes

29Inflammation

Page 30: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Lyme

Cardiovascular [1] [2]

Osteoarthritis

Obesity

Autism

Depression

Autoimmune Disorders

rheumatoid arthritis

lupus

asthma

inflammatory bowel diseases (ulcerative colitis, Crohn’s)

1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heartfailure. Eur Heart J. 1999; 20: 683–693

2Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol.1996; 27: 1201–1206

30Inflammation

Page 31: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Cytokines

Proinflammatory

Il-1

Il-6

IL-8

TNF-alpha

31

Page 32: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

32

Page 33: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

33

Page 34: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

34

Page 35: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

35

Page 36: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Neuroinflammation:

The Brain on Fire36

Page 37: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Pathology of Depression

37

Page 38: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Vargas DL. Et al. Neuroglial activation and

neuroinflammation in the brain of patients with

autism. Annals of Neurology. 2005. 57,67-81.

A: normal cerebellum in

control patient

B-C: atrophic

cerebellum in a patient

with autism with loss of

purkinje and granular

cells

D-K: activated microglial

and inflammatory cells

38

Page 39: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Digestive

Symptoms

39

Page 40: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

40

Page 41: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Disrupted

Gut-Brain-

Microbiome:

Leads to

Leaky Gut

41

Page 42: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

42

Page 43: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Disrupted Gut-Brain-Microbiome in

Autism Spectrum Disorder

40 autistic subjects (36 out of 40 autistic subjects were classified as severe ASDs, Childhood Autism Rating Scale (CARS) value >37) and 40 neurotypical controls

Analysis of gut microbiota

Results:

Candida was more than double in the autistic than neurotypical subjects

Significant increase in the Firmicutes/Bacteroidetes ratio in autistic subjects due to a reduction of the Bacteroidetes relative abundance

Strati F. et al. New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 2017. 5:24.

43

Page 44: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Effect of Probiotics on

Alzheimer’s disease

60 Patients with Alzheimer’s disease randomized to 30 patients taking probiotics versus 30 patients on placebo for 12 weeks

Results: Patients on probiotics

Significant improvement in Mini-mental state exam (p<0.0001)

Decreased plasma malondialdehyde levels

Decreased CRP

Decreased TG’s

Akbari E. et al. Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer’s disease: A randomized, double-blind controlled trial. Frontiers in Aging NeuroScience. 2016. Volume 8(256).

44

Page 45: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Depression Depression

45

Page 46: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Genetic Influences 46

Page 47: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

47Chronic Pathology

Chronic Disease

Page 48: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Oxidative stress, mitochondrial dysfunction and, inflammationcommon events in skin of patients with Fibromyalgia. Sanchez-Dominguez B. Mitochondrion. 2015 Mar;21:69-75.

Recent studies have shown some evidence demonstrating that oxidative stress, mitochondrial dysfunction andinflammation may have a role in the pathophysiology of fibromyalgia.

Skin biopsies from patients showed a significant mitochondrial dysfunctionwith reduced mitochondrial chain activities and bioenergetics levels and increased levels of oxidative stress.

OS, mitochondrial dysfunction andinflammation as interdependent events in the pathophysiology of FM

48

Page 49: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Neurodegeneration49

Page 50: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Peacock BN, Gherezghiher TB, Hilario JD, Kellermann GH. New insights into

Lyme disease. Redox Biology. 2015;5:66-70.

50

Page 51: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Diabetes

and

Cardiac

Disease

51

Page 52: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Treatment for chronic disease

Repair and support mitochondria

•Membrane repair

•Support nutrients in ATP production from breakdown of macronutrients to Krebs cycle to oxidative phosphorylation

1

Decrease causes of oxidative stress and inflammation

2Increase anti-oxidants to counteract oxidative stress including activating Nrf2

3Decrease inflammation through down regulating inflammatory mediators and improving microbiome

4

52

Page 53: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Diagnosis of Mitochondrial

Dysfunction

Urine organic acids (OAT)

Blood Lactate and pyruvate

Plasma Acyl-carnitine profile

CoQ10 levels

Liver enzymes and ammonia

Quantitative amino acids

Creatinine kinase

Mitochondrial Disease: additional testing

muscle biopsy, genetic profiles, echocardiogram, analysis of cerebral spinal fluid

53

Page 54: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

54

Page 55: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Mitochondrial Dysfunction

Repair mitochondrial membrane

Phospholipids

55

Page 56: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

56

Repair mitochondrial membranePhospholipids

Support mitochondrial functionCoQ10/UbiquinolCarnitineNADHAlpha-lipoic acidB vitaminsVitamin E

MITOCHONDRIAL DYSFUNCTION

Page 57: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Support

for

oxidative

stress

Anti-oxidants to combat oxidative stress

Glutathione

Molecular Hydrogen (H2 : Hydrogen gas)

Vitamin E: mixed tocopherols and tocotrienols

Curcumin

Tea: EGCG

Resveratrol

N-acetyl-cysteine

57

Page 58: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Diagnosis:Oxidative Stress

Test for DNA/RNA damage: 8-hydroxydeoxyguanosine (8-OHdG)

Urine and blood

Test for lipid peroxidation: 8-isoprostane

Urine and blood

Anti-oxidant Reserves and enzyme function: Total antioxidant capacity, glutathione peroxidase, superoxide dismutase (SOD) Blood tests

Glutathione blood level (Need to draw and put on ice immediately to be accurate)

58

Page 59: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Molecular Hydrogen: H2

Hydrogen gas is very stable molecule

Neutralizes harmful free radicals, including the hydroxyl radical1

Hydrogen electron donation turns hydroxyl into water

Diffuses across membranes, including mitochondria, due to its small size2

Most antioxidant supplements are limited in their cellular distributions and are poorly taken up by organelles like mitochondria 3

Hydrogen has the ability to effectively penetrate biomembranes and infiltrate into organelles, such as mitochondria and the nucleus 3

In contrast to many antioxidants, H2 also has the advantage of being able to penetrate the blood-brain barrier 3

59

Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals, Ikuroh Ohsawa, et al. Nature Medicine Vol 13, No. 6, June 20072 Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine, Ohta S., Pharmacology & Therapeutics, Volume 144, Issue 1, October 2014, Pages 1–113Clinical Effects of Hydrogen Administration: From Animal and Human Diseases to Exercise Medicine, Nicolson G. et al., International Journal of Clinical Medicine, 2016, 7, 32-76

Page 60: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Molecular Hydrogen: H2

Summary

Anti-oxidant for dangerous hydroxyl radical without destroying free radicals needed for metabolism

Activates Nrf2 anti-oxidant cascade including glutathione peroxidase, catalase, and superoxide dismutase (SOD)

Decreases pro-inflammatory cytokines through cell signaling

Promotes mitochondrial ATP energy function

1Molecular hydrogen as a preventive and therapeutic medical gas: initiation, development and potential of hydrogen medicine, Ohta S., Pharmacology & Therapeutics, Volume 144, Issue 1, October 2014, Pages 1–11

2Clinical Effects of Hydrogen Administration: From Animal and Human Diseases to Exercise Medicine, Nicolson G. et al., International Journal of Clinical Medicine, 2016, 7, 32-76

60

Page 61: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Neuroinflammation: Molecular Hydrogen

Research: animal study with hydrogen rich saline

3 groups: control, induced amyloid-beta neural inflammation, and induced amyloid inflammation plus hydrogen saline

Results:

Hydrogen-saline prevented amyloid-beta induced neuroinflammation and oxidative stress

Wang C et al. Hydrogen-rich saline reduces oxidative stress and inflammation by inhibition of JNK and NF-KB activation in a rat model of amyloid-beta induced Alzheimer’s disease. Neuroscience Letters. 2011. 491(2):127-132.

61

Page 62: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Molecular Hydrogen:Parkinson’s Disease

62

Randomized placebo controlled trial

48 weeks consuming either 1000 ml of molecular hydrogen water or placebo

Results

Statistically significant improvement in the molecular hydrogen group: Unified Parkinson’s Disease Rating Scale (UDPRS)

Worsening disease rating in the placebo group

Yoritaka, A., et al., Pilot study of H(2) therapy in Parkinson’s disease: A randomized double-blind placebo-controlled trial. Movement Disorders, 2013.

Page 63: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Support for Inflammation and Abnormal Cytokines

Glutathione

Molecular Hydrogen (H2 : Hydrogen gas)

Vitamin E: mixed tocopherols and tocotrienols

Curcumin

Tea: EGCG

Resveratrol

N-acetyl-cysteine

Probiotics

Omega 3 fatty acids

Boswellia

White willow bark

63

Page 64: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Goal: Activate Nrf2:

Nuclear Factor 2

Master regulator of the

antioxidant system

Mechanism: A Nrf2

activator releases protein

into the cell nucleus where

it binds to DNA and

activates anti-oxidant

enzymes such as catalase,

glutathione peroxidase,

and superoxide dismutase

and these enzymes can

neutralize up to 1 million

free radicals

64

Page 65: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Goal:

Block

NFKB

65

Page 66: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

Dr. Debby Hamilton, MD, MPH

[email protected]

66

Page 67: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

References for Glutathione

Cooke RW. Et al Reduction of oxidative stress marker in lung fluid of preterm infants after

administration of intra-tracheal liposomal glutathione. Bio Neonate. 2005;87(3):178-80.

Hauser AR. Et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in

Parkinson's disease. Mov Disord. 2009 May 15;24(7):979-83. doi: 10.1002/mds.22401.

James J. Et al. Am J Clin Nutr 2004;80:1611-161

Kern JK. Et al. A clinical trial of glutathione supplementation in autism spectrum disorders. Med

Sci Monit. 2011; 17(12): CR677–CR682

Madrigal JL. Et al. glutathione depletion, lipid peroxidation and mitochondrial dysfunction are

induced by chronic stress in rat brain. Neuropsychopharm. 2001. 24(4).

Marí M. et al. Mitochondrial Glutathione, a Key Survival Antioxidant. Antioxidants & Redox

Signaling. 2009;11(11):2685-2700.

Morris G. et al. The glutathione system: a new drug target in neuroimmune disorders. Mol

Neurobiol. 2014 Dec;50(3):1059-84.

Sechi G. Et al. Reduced intravenous glutathione in the treatment of early Parkinson's disease

Prog Neurospychopharm Biol Psych. 1996 Oct;20(7):1159-70.

Sinha R. Et al. Oral supplementation with liposomal glutathione elevates body stores of

glutathione and markers of immune function. European Journal of Clinical Nutrition advance

online publication, 30 August 2017; doi:10.1038/ejcn.2017.132. (Tri-Fortify™ study)

67

Page 68: The Underlying Pathology of Chronic Disease...1 Anker SD et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.

References for Molecular Hydrogen

Ichihara, M., et al., Beneficial biological effects and the underlying mechanisms of molecular

hydrogen - comprehensive review of 321 original articles. Med Gas Res, 2015. 5: p. 12.

Ohta, S., Molecular hydrogen as a preventive and therapeutic medical gas: initiation,

development and potential of hydrogen medicine. Pharmacol Ther. 2014.

Molecular hydrogen foundation: www.molecularhydrogenfoundation.com

Yu, J., et al., Molecular hydrogen attenuates hypoxia/reoxygenation injury of intrahepatic

cholangiocytes by activating Nrf2 expression. Toxicol Lett. 2015. 238(3): p. 11-19.

Ohno, K., M. Ito, and M. Ichihara, Molecular hydrogen as an emerging therapeutic medical

gas for neurodegenerative and other diseases. Oxidative Medicine and Cellular Longevity.

2012. 2012: p. 353152.

Dixon, B.J., J. Tang, and J.H. Zhang, The evolution of molecular hydrogen: a noteworthy

potential therapy with clinical significance. Med Gas Res. 2013. 3(1): p. 10.

Dohi, K., et al., Molecular Hydrogen in Drinking Water Protects against Neurodegenerative

Changes Induced by Traumatic Brain Injury. PLoS One. 2014. 9(9): p. e108034.

Saitoh Y, et al. Biological safety of neutral-pH hydrogen-enriched electrolyzed water upon

mutagenicity, genotoxicity, and subchronic oral toxicity. Toxicology and Industrial Health.

2010. 26(4):203-216.

68


Recommended